Skip to main content
. 2021 Oct 17;13(20):5204. doi: 10.3390/cancers13205204

Table 2.

JAK Family Inhibitors not in Clinical Development.

Drug Name Mechanism Indication NCT # Trial Phase Outcome
NVP-BSK805 Jak2 inhibitor (Type 1) 0
CEP-33779 Jak2 > Jak3 inhibitor (Type 1) 0
TG101209 Jak2 inhibitor (type I) 0
AZ960 Jak2 inhibitor (Type 1) 0
CHZ868 Jak2 inhibitor (Type 2) 0
ON044580 Jak2/BCR-ABL dual inhibitor (allosteric) 0
ZT55 Jak2 inhibitor 0